المؤلفون: Dieng M; NHMRC Clinical Trials Centre, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia. mbathio.dieng@sydney.edu.au., Lord SJ; NHMRC Clinical Trials Centre, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia., Turner RM; Centre for Biostatistics, University of Otago, Dunedin, New Zealand., Nieweg OE; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital and Mater Hospitals, Sydney, NSW, Australia., Menzies AM; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia.; Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia., Saw RPM; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital and Mater Hospitals, Sydney, NSW, Australia., Einstein AJ; Seymour, Paul, and Gloria Milstein Division of Cardiology, Department of Medicine, and Department of Radiology, Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York, NY, USA., Emmett L; Department of Theranostics and Nuclear Medicine, St Vincent's Hospital Sydney, Sydney, NSW, Australia., Thompson JF; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital and Mater Hospitals, Sydney, NSW, Australia., Lo SN; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia., Morton RL; NHMRC Clinical Trials Centre, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia.; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.

المصدر: Annals of surgical oncology [Ann Surg Oncol] 2022 May; Vol. 29 (5), pp. 2871-2881. Date of Electronic Publication: 2022 Feb 10.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma*/diagnostic imaging , Melanoma*/surgery , Skin Neoplasms*/diagnostic imaging , Skin Neoplasms*/surgery, Chronic Disease ; Humans ; Neoplasm Recurrence, Local/diagnostic imaging ; Neoplasm Recurrence, Local/surgery ; Neoplasm Staging ; Positron Emission Tomography Computed Tomography/methods ; Melanoma, Cutaneous Malignant

المؤلفون: Dieng M; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, Australia. mbathio.dieng@sydney.edu.au.; School of Public Health, The University of Sydney, Camperdown, Australia. mbathio.dieng@sydney.edu.au., Lord SJ; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, Australia., Nieweg OE; Melanoma Institute Australia, Wollstonecraft, Australia.; Sydney Medical School, The University of Sydney, Camperdown, Australia., Saw RPM; Melanoma Institute Australia, Wollstonecraft, Australia., Einstein AJ; Department of Medicine, Seymour, Paul, and Gloria Milstein Division of Cardiology, Columbia University Irving Medical Center, New York, USA.; Department of Radiology, Seymour, Paul, and Gloria Milstein Division of Cardiology, Columbia University Irving Medical Center, New York, USA., Nijhuis AAG; Melanoma Institute Australia, Wollstonecraft, Australia., Turner RM; Biostatistics, University of Otago, Dunedin, New Zealand., Thompson JF; Melanoma Institute Australia, Wollstonecraft, Australia., Morton RL; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, Australia.

المصدر: Annals of surgical oncology [Ann Surg Oncol] 2021 Dec; Vol. 28 (Suppl 3), pp. 819-820. Date of Electronic Publication: 2021 May 02.

نوع المنشور: Letter; Comment

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma*/diagnostic imaging , Positron Emission Tomography Computed Tomography*, Fluorodeoxyglucose F18 ; Humans

المؤلفون: Turner RM; Centre for Biostatistics, University of Otago, Dunedin, New Zealand., Dieng M; NHMRC Clinical Trials Centre, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia. mbathio.dieng@sydney.edu.au., Khanna N; NHMRC Clinical Trials Centre, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia., Nguyen M; NHMRC Clinical Trials Centre, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia., Zeng J; Preventive and Social Medicine, University of Otago, Dunedin, New Zealand., Nijhuis AAG; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia., Nieweg OE; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia., Einstein AJ; Seymour, Paul, and Gloria Milstein Division of Cardiology, Department of Medicine, and Department of Radiology, Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York, NY, USA., Emmett L; Department of Theranostics and Nuclear Medicine, St Vincent's Hospital Sydney, Darlinghurst, NSW, Australia., Lord SJ; NHMRC Clinical Trials Centre, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia., Menzies AM; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia., Thompson JF; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia., Saw RPM; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia., Morton RL; NHMRC Clinical Trials Centre, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia.; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.

المصدر: Annals of surgical oncology [Ann Surg Oncol] 2021 Aug; Vol. 28 (8), pp. 4561-4569. Date of Electronic Publication: 2021 Jan 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma*/diagnostic imaging , Melanoma*/pathology , Melanoma*/surgery , Positron Emission Tomography Computed Tomography*, Australia ; Fluorodeoxyglucose F18 ; Humans ; Neoplasm Recurrence, Local/diagnostic imaging ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/surgery ; Neoplasm Staging ; Positron-Emission Tomography ; Radiopharmaceuticals ; Retrospective Studies ; Sensitivity and Specificity ; Tomography, X-Ray Computed

المؤلفون: Nijhuis AAG; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; University of Utrecht, Utrecht, The Netherlands., Dieng M; NHMRC Clinical Trials Centre, University of Sydney, Level 6, Medical Foundation Building, 92-94 Parramatta Road, Camperdown, NSW, 2050, Australia., Khanna N; NHMRC Clinical Trials Centre, University of Sydney, Level 6, Medical Foundation Building, 92-94 Parramatta Road, Camperdown, NSW, 2050, Australia., Lord SJ; NHMRC Clinical Trials Centre, University of Sydney, Level 6, Medical Foundation Building, 92-94 Parramatta Road, Camperdown, NSW, 2050, Australia., Dalton J; Poche Centre, Clinical Trials, Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia., Menzies AM; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia., Turner RM; Biostatistics Unit, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand., Allen J; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia., Saw RPM; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia., Nieweg OE; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia., Thompson JF; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia., Morton RL; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. rachael.morton@ctc.usyd.edu.au.; NHMRC Clinical Trials Centre, University of Sydney, Level 6, Medical Foundation Building, 92-94 Parramatta Road, Camperdown, NSW, 2050, Australia. rachael.morton@ctc.usyd.edu.au.

المصدر: Annals of surgical oncology [Ann Surg Oncol] 2019 Jun; Vol. 26 (6), pp. 1860-1868. Date of Electronic Publication: 2019 Mar 25.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Incidental Findings*, Melanoma/*pathology , Neoplasm Recurrence, Local/*pathology , Positron Emission Tomography Computed Tomography/*methods, False Positive Reactions ; Female ; Follow-Up Studies ; Humans ; Male ; Melanoma/diagnostic imaging ; Middle Aged ; Neoplasm Recurrence, Local/diagnostic imaging ; Neoplasm Staging ; Prospective Studies ; Radiopharmaceuticals

المؤلفون: Fisher OM; Gastroesophageal Cancer Program, St. Vincent's Centre for Applied Medical Research, Sydney, Australia.; School of Medical Sciences, UNSW Australia, Sydney, Australia.; Department of Surgery, School of Medicine, University of Notre Dame, Sydney, Australia., Levert-Mignon AJ; Gastroesophageal Cancer Program, St. Vincent's Centre for Applied Medical Research, Sydney, Australia., Lehane CW; Gastroesophageal Cancer Program, St. Vincent's Centre for Applied Medical Research, Sydney, Australia., Botelho NK; Gastroesophageal Cancer Program, St. Vincent's Centre for Applied Medical Research, Sydney, Australia., Maag JL; School of Medical Sciences, UNSW Australia, Sydney, Australia.; Genomics & Epigenetics Division, Garvan Institute of Medical Research, Sydney, Australia., Thomas ML; Gastroesophageal Cancer Program, St. Vincent's Centre for Applied Medical Research, Sydney, Australia., Edwards M; Douglass Hanley Moir Pathology, Sydney, Australia., Lord SJ; Gastroesophageal Cancer Program, St. Vincent's Centre for Applied Medical Research, Sydney, Australia.; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia.; Department of Surgery, School of Medicine, University of Notre Dame, Sydney, Australia., Bobryshev YV; Gastroesophageal Cancer Program, St. Vincent's Centre for Applied Medical Research, Sydney, Australia., Whiteman DC; QIMR Berghofer Medical Research Institute, Brisbane, Australia., Lord RV; Gastroesophageal Cancer Program, St. Vincent's Centre for Applied Medical Research, Sydney, Australia. rvlord@stvincents.com.au.; Department of Surgery, School of Medicine, University of Notre Dame, Sydney, Australia. rvlord@stvincents.com.au.

المصدر: Annals of surgical oncology [Ann Surg Oncol] 2016 Dec; Vol. 23 (Suppl 5), pp. 746-754. Date of Electronic Publication: 2016 Aug 30.

نوع المنشور: Journal Article; Validation Study

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Esophagogastric Junction* , Gene Expression*, Adenocarcinoma/*genetics , Esophageal Neoplasms/*genetics , Tetraspanin 24/*genetics, Adenocarcinoma/metabolism ; Adenocarcinoma/pathology ; Adenocarcinoma/therapy ; Aged ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Chemoradiotherapy, Adjuvant ; Esophageal Neoplasms/metabolism ; Esophageal Neoplasms/pathology ; Esophageal Neoplasms/therapy ; Esophagectomy ; Female ; Gene Expression Profiling ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Neoplasm Staging ; Prognosis ; Proportional Hazards Models ; Survival Rate ; Tetraspanin 24/metabolism

المؤلفون: Fisher OM; St. Vincent's Centre for Applied Medical Research, Sydney, Australia., Levert-Mignon AJ, Lord SJ, Botelho NK, Freeman AK, Thomas ML, Falkenback D, Wettstein A, Whiteman DC, Bobryshev YV, Lord RV

المصدر: Annals of surgical oncology [Ann Surg Oncol] 2015 Jul; Vol. 22 (7), pp. 2431-8. Date of Electronic Publication: 2014 Oct 28.

نوع المنشور: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Adenocarcinoma/*metabolism , Barrett Esophagus/*metabolism , Cathepsin E/*blood , Esophageal Neoplasms/*metabolism , Esophagus/*metabolism , Metaplasia/*metabolism , Precancerous Conditions/*metabolism, Adenocarcinoma/mortality ; Adenocarcinoma/pathology ; Aged ; Barrett Esophagus/mortality ; Barrett Esophagus/pathology ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Case-Control Studies ; Cathepsin E/genetics ; Enzyme-Linked Immunosorbent Assay ; Esophageal Neoplasms/mortality ; Esophageal Neoplasms/pathology ; Female ; Follow-Up Studies ; Humans ; Immunoenzyme Techniques ; Male ; Metaplasia/mortality ; Metaplasia/pathology ; Middle Aged ; Neoplasm Staging ; Precancerous Conditions/mortality ; Precancerous Conditions/pathology ; Prognosis ; RNA, Messenger/genetics ; Real-Time Polymerase Chain Reaction ; Reverse Transcriptase Polymerase Chain Reaction ; Survival Rate